Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07322913 · ClinicalTrials.gov registry record
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
A clinical trial of Aortic Diseases and Carotid Artery Diseases, sponsored by Intervascular.
- Recruiting
- Registry status
- 1,200
- Enrollment target
- 3
- Study locations
NCT07322913 is a study of Aortic Diseases and Carotid Artery Diseases that is actively recruiting participants, run by Intervascular. The registered enrollment target is 1,200 participants, below the 1,381-participant average among 7 other Aortic Diseases trials with a reported enrollment target (13% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT07322913, a study of Aortic Diseases and Carotid Artery Diseases, is actively recruiting participants, sponsored by Intervascular.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this registry is to evaluate the long-term safety and performance of Intervascular Vascular Grafts and Patches (Intergard Standard, Hemashield, Intergard Silver, Intergard Synergy) for bypass, repair or replacement of aortic, peripheral, or carotid arteries. This registry is intended to further define the expected product lifetime of the devices and to collect data related to usefulness of the antimicrobial coatings.
Conditions Studied
Interventions
- DEVICE Intergard Standard - Collagen Coated Vascular Grafts and Patches
- DEVICE Hemashield - Collagen Coated Vascular Grafts and Patches
- DEVICE Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches
- DEVICE Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts
Study Locations (3)
Other
- CHU Dijon Bourgogne - Dijon
- Hospital Universitario de Navarra - Pamplona
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2025-12-19 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07322913
The ClinicalTrials.gov registry entry for NCT07322913 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,381-participant average among 7 other Aortic Diseases trials with a reported enrollment target (13% lower). The listed sponsor is Intervascular, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Aortic Diseases appearing as the primary indexed condition, and to 4 interventions - of which Intergard Standard - Collagen Coated Vascular Grafts and Patches is the first listed.
NCT07322913 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07322913 about?
NCT07322913 is a clinical study titled "Intervascular Post-Market Clinical Follow-Up (PMCF) Registry". The purpose of this registry is to evaluate the long-term safety and performance of Intervascular Vascular Grafts and Patches (Intergard Standard, Hemashield, Intergard Silver, Intergard Synergy) for bypass, repair or replacement of aortic, peripheral, or carotid arteries. This registry is intended ...
What is the current status of trial NCT07322913?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2025-12-19. Estimated completion is 2026-12.
What conditions does trial NCT07322913 study?
This clinical trial studies the following conditions: Aortic Diseases, Carotid Artery Diseases, Peripheral Arterial Diseases.
What interventions are being tested in trial NCT07322913?
The interventions under investigation include: Intergard Standard - Collagen Coated Vascular Grafts and Patches (DEVICE), Hemashield - Collagen Coated Vascular Grafts and Patches (DEVICE), Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches (DEVICE), Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts (DEVICE).
Who is sponsoring clinical trial NCT07322913?
This trial is sponsored by Intervascular, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07322913 being conducted?
This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
RECRUITING
-
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
RECRUITING · NA
-
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
RECRUITING · NA
-
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
RECRUITING
-
Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters
RECRUITING · Phase 4
-
Development of CIRC Technologies
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.